Oct 25, 2019 - Gilead (GILD) falls short of earnings estimates but marginally beats on sales in the third quarter of 2019.
Oct 24, 2019 - CLB earnings call for the period ending September 30, 2019.
Oct 24, 2019 - The following slide deck was published by Arcadis NV in conjunction with their 2019 Q3 earnings call.
Oct 24, 2019 - Core Laboratories NV (NYSE:CLB) Q3 2019 Earnings Conference Call October 24, 2019, 08:30 ET Company Participants David Demshur - CEO & Chairman Gwendolyn Schreffler - SVP, Corporate Development &a
Oct 23, 2019 - MELEXIS NV IEPER (OTC:MLXSF) Q3 2019 Earnings Conference Call October 23, 2019 11:00 ET Company Participants Françoise Chombar - CEO Karen Van Griensven - CFO Conference Call Participants Matthias Mae
Oct 23, 2019 - Glaxo's (GSK) Vaccines and Respiratory segments are likely to have driven sales growth in the third quarter.
Oct 23, 2019 - The following slide deck was published by MELEXIS NV IEPER in conjunction with their 2019 Q3 earnings call.
Oct 22, 2019 - Novartis AG (NYSE:NVS) Q3 2019 Results Earnings Conference Call October 22, 2019, 08:00 AM ET Company Participants Samir Shah - Global Head of IR Vasant Narasimhan - CEO Harry Kirsch - CFO John Tsai -
Oct 22, 2019 - Four drug/biotech stocks are scheduled to release third-quarter results on Oct 23. Let's see how these companies are placed before their earnings call.
Oct 22, 2019 - Novartis (NVS) beats sales estimates in the third quarter of 2019, driven by robust performance of key drugs and increased contribution from new launches.